14-day Premium Trial Subscription Try For FreeTry Free
$4.45
-0.0300 (-0.670%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 BCRX stock ended at $4.45. This is 0.670% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.66% from a day low at $4.42 to a day high of $4.67.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical BioCryst Pharmaceuticals prices

Date Open High Low Close Volume
May 13, 2020 $5.30 $5.50 $4.60 $4.90 16 262 871
May 12, 2020 $6.17 $6.29 $5.37 $5.41 23 453 066
May 11, 2020 $5.05 $5.67 $5.01 $5.54 24 353 626
May 08, 2020 $3.92 $4.78 $3.92 $4.70 21 134 358
May 07, 2020 $3.87 $4.00 $3.77 $3.92 8 412 636
May 06, 2020 $4.06 $4.16 $3.82 $3.86 12 271 901
May 05, 2020 $4.15 $4.31 $3.85 $3.95 13 306 008
May 04, 2020 $3.45 $3.93 $3.38 $3.93 9 217 921
May 01, 2020 $3.75 $3.85 $3.37 $3.54 11 535 485
Apr 30, 2020 $3.84 $4.14 $3.73 $3.91 16 075 812
Apr 29, 2020 $3.83 $4.00 $3.45 $3.70 26 536 773
Apr 28, 2020 $3.57 $3.57 $3.21 $3.34 7 376 370
Apr 27, 2020 $3.70 $3.79 $3.43 $3.55 11 582 272
Apr 24, 2020 $3.06 $3.65 $3.03 $3.56 12 270 122
Apr 23, 2020 $3.50 $3.66 $2.75 $3.26 28 140 569
Apr 22, 2020 $3.40 $3.49 $3.25 $3.45 6 720 636
Apr 21, 2020 $3.47 $3.51 $3.03 $3.21 12 424 510
Apr 20, 2020 $3.34 $3.84 $3.33 $3.47 21 137 571
Apr 17, 2020 $3.08 $3.36 $2.90 $3.36 26 335 952
Apr 16, 2020 $2.72 $2.90 $2.50 $2.59 9 556 002
Apr 15, 2020 $2.67 $2.79 $2.55 $2.70 8 373 255
Apr 14, 2020 $2.43 $2.95 $2.36 $2.76 23 545 945
Apr 13, 2020 $2.70 $2.75 $2.24 $2.35 26 775 538
Apr 09, 2020 $2.00 $2.15 $1.99 $2.07 5 776 242
Apr 08, 2020 $1.95 $2.01 $1.94 $2.00 3 885 060
Click to get the best stock tips daily for free!

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II... BCRX Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT